SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-043083
Filing Date
2023-11-29
Accepted
2023-11-29 17:00:40
Documents
84
Period of Report
2022-12-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-a.htm   iXBRL 8-K/A 65088
2 ex23-1.htm EX-23.1 3407
3 ex99-2.htm   iXBRL EX-99.2 894355
4 ex99-3.htm EX-99.3 298435
5 ex99-4.htm EX-99.4 174108
  Complete submission text file 0001493152-23-043083.txt   7311502

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ntbl-20221231.xsd EX-101.SCH 56294
7 XBRL CALCULATION FILE ntbl-20221231_cal.xml EX-101.CAL 64045
8 XBRL DEFINITION FILE ntbl-20221231_def.xml EX-101.DEF 439822
9 XBRL LABEL FILE ntbl-20221231_lab.xml EX-101.LAB 396644
10 XBRL PRESENTATION FILE ntbl-20221231_pre.xml EX-101.PRE 445775
78 EXTRACTED XBRL INSTANCE DOCUMENT form8k-a_htm.xml XML 1098703
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36581 | Film No.: 231453107
SIC: 2834 Pharmaceutical Preparations